Kytopure Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Kytopure General Information


Provider of drug delivery and medical products. The company develop and market a series of clinically significant therapies and products based on its N,O- carboxymethylchitosan chitosan (NOCC) derived technology and its sulfated derivative s-NOCC.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Other Healthcare Services
Primary Office
  • 1 Research Drive
  • Dartmouth, Nova Scotia B2Y 4M9
  • Canada
+1 (902) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kytopure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Kytopure’s complete valuation and funding history, request access »

Kytopure Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovacorp Venture Capital Minority 000 0000 000000 0
To view Kytopure’s complete investors history, request access »